World-first use of base-edited CAR T cells to treat resistant leukemia

Corporate businessmen working on tablet at office

A patient with relapsed T cell leukaemia has been given base-edited T-cells in a world-first use of a base-edited cell therapy, in a ‘bench-to-bedside’ collaboration between UCL and Great Ormond Street Hospital for Children (GOSH).

The best part of ‘White Lotus’ is the online community it’s created

Previous article

Troubleshooting the mystery of post-COVID insomnia with a sleep tracker

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations